Richard Reynolds Selected Research

Cyclophosphamide (Cytoxan)

9/2013

Non-myeloablative autologous haematopoietic stem cell transplantation expands regulatory cells and depletes IL-17 producing mucosal-associated invariant T cells in multiple sclerosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Richard Reynolds Research Topics

Disease

37	Multiple Sclerosis 07/2022 - 09/2002
21	Inflammation (Inflammations) 07/2022 - 02/2006
17	Demyelinating Diseases (Demyelinating Disease) 07/2022 - 07/2002
6	Disease Progression 10/2022 - 09/2002
5	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 07/2012 - 07/2002
4	Necrosis 11/2022 - 12/2013
3	Neuroinflammatory Diseases 10/2021 - 07/2008
3	Parkinson Disease (Parkinson's Disease) 10/2021 - 08/2012
3	Cognitive Dysfunction 01/2021 - 09/2014
3	Neurodegenerative Diseases (Neurodegenerative Disease) 07/2015 - 04/2006
2	Alzheimer Disease (Alzheimer's Disease) 11/2022 - 08/2012
2	Atrophy 01/2021 - 01/2016
2	Chronic Progressive Multiple Sclerosis 01/2016 - 12/2013
2	Gliosis 07/2012 - 06/2012
1	Neurobehavioral Manifestations 01/2022
1	Stroke (Strokes) 08/2019
1	Prion Diseases (Transmissible Spongiform Encephalopathies) 07/2019
1	Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease) 07/2019
1	Autoimmune Diseases (Autoimmune Disease) 01/2018
1	Seizures (Absence Seizure) 01/2016
1	Central Nervous System Diseases (CNS Diseases) 01/2016
1	Acquired Immunodeficiency Syndrome (AIDS) 07/2013
1	Rheumatoid Arthritis 03/2012
1	Human Influenza (Influenza) 01/2012
1	Epstein-Barr Virus Infections 07/2010
1	Relapsing-Remitting Multiple Sclerosis 02/2010

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 10/2022 - 04/2006
9	CytokinesIBA 01/2021 - 12/2008
7	Myelin-Oligodendrocyte GlycoproteinIBA 07/2022 - 07/2002
6	Biomarkers (Surrogate Marker)IBA 10/2021 - 01/2015
5	RNA (Ribonucleic Acid)IBA 12/2019 - 01/2010
4	Complement System Proteins (Complement)IBA 01/2022 - 01/2016
4	Mitochondrial DNA (mtDNA)IBA 08/2021 - 03/2011
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 12/2008
3	Type I Tumor Necrosis Factor ReceptorsIBA 10/2022 - 12/2019
3	Glutamic Acid (Glutamate)FDA Link 12/2020 - 02/2010
3	Connexin 43 (Connexin43)IBA 09/2014 - 06/2012
3	AntibodiesIBA 06/2014 - 07/2002
3	Messenger RNA (mRNA)IBA 12/2013 - 01/2010
2	ParvalbuminsIBA 10/2022 - 01/2021
2	Lymphotoxin-alpha (Lymphotoxin)IBA 07/2022 - 12/2020
2	Neurotransmitter Agents (Neurotransmitter)IBA 10/2021 - 01/2018
2	ProteomeIBA 01/2021 - 01/2020
2	InterferonsIBA 12/2020 - 12/2020
2	HLA-DR15 antigenIBA 11/2020 - 01/2018
2	IronIBA 11/2019 - 07/2015
2	Interleukin-10 (Interleukin 10)IBA 01/2018 - 01/2008
2	ChemokinesIBA 01/2016 - 07/2008
2	PK 11195 (PK11195)IBA 01/2015 - 05/2014
2	incomplete Freund's adjuvantIBA 12/2013 - 07/2013
2	Pharmaceutical PreparationsIBA 03/2012 - 05/2009
2	polysialyl neural cell adhesion moleculeIBA 03/2007 - 09/2002
1	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2022
1	Phosphotransferases (Kinase)IBA 11/2022
1	PrebioticsIBA 10/2021
1	SynucleinsIBA 10/2021
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2021
1	Carisoprodol (Soma)FDA LinkGeneric 01/2021
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 12/2020
1	N-Methylaspartate (NMDA)IBA 12/2020
1	InterleukinsIBA 05/2020
1	Interleukin-9 (Interleukin 9)IBA 05/2020
1	Type II Tumor Necrosis Factor ReceptorsIBA 12/2019
1	Cytidine Triphosphate (CTP)IBA 08/2019
1	NeuropeptidesIBA 01/2018
1	Cholinergic Agents (Cholinergics)IBA 01/2018
1	GalaninIBA 01/2018
1	lactacystinIBA 01/2018
1	Interleukin-2 (IL2)IBA 01/2018
1	Interleukin-6 (Interleukin 6)IBA 01/2018
1	Oligoclonal BandsIBA 01/2017
1	Natalizumab (Tysabri)FDA Link 01/2016
1	Immunoglobulins (Immunoglobulin)IBA 01/2016
1	ParaffinIBA 01/2016
1	gamma-Aminobutyric Acid (GABA)IBA 01/2016
1	Formaldehyde (Formol)FDA Link 01/2016
1	Potassium Channels (Potassium Channel)IBA 06/2014
1	Interferon-gamma (Interferon, gamma)IBA 12/2013
1	Alemtuzumab (Campath)FDA Link 09/2013
1	Interleukin-17 (Interleukin 17)IBA 09/2013
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 09/2013
1	Glycoproteins (Glycoprotein)IBA 07/2013
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 07/2013
1	CalreticulinIBA 07/2013
1	PolymersIBA 07/2013
1	EnzymesIBA 03/2012
1	dimethylethylsilylimidazoleIBA 03/2012
1	Natural Cytotoxicity Triggering Receptor 1IBA 01/2012
1	LigandsIBA 01/2012
1	Biological ProductsIBA 01/2012
1	Indicators and Reagents (Reagents)IBA 10/2010
1	B-Cell Activating FactorIBA 07/2010
1	Sphingosine-1-Phosphate ReceptorsIBA 02/2010

Therapy/Procedure

3	Therapeutics 01/2018 - 02/2006
1	Injections 07/2022
1	Transplantation 10/2021
1	Diet Therapy (Therapy, Diet) 10/2021
1	Immunotherapy 09/2013
1	Stem Cell Transplantation 09/2013
1	Intradermal Injections 07/2013